Patient access to medical cannabis October figures released by Rhys Cohen 1. Record growth continues Another record month for medicinal cannabis approvals in Australia via the Special Access Scheme Category…

Australia’s Most Comprehensive Medicinal Cannabis Patient, Product and Pricing Analysis released FreshLeaf Analytics has released Australia’s most comprehensive medicinal cannabis Patient, Product and Pricing Analysis. The study was conducted in…

The last 2 years have seen a huge amount of speculation in Australia around medicinal cannabis stocks. A number of companies have listed on the ASX, raising substantial amounts of…

Australian media has in recent years reported on the high costs of medicinal cannabis (also known as medicinal marijuana), quoting numbers as high as $40K per year for patient treatment.…

FreshLeaf Analytics, in collaboration with Cannabis Access Clinics has released Australia’s first pricing analysis for legal medicinal cannabis The study was conducted in Q3 2018 and includes insights into the…